Importantly, no upregulation of AKR1C3 mRNA was detected upon ZAN treatment of HepG2 or KG1α cells, suggesting that ZAN does not affect systemic DAUN metabolism or influence the resistance of cancer cells to DAUN by promoting changes in AKR1C3 expression. The gene discussed is ZAN; the disease is cancer.